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Abstract
Background: Current intra-domiciliary vector control depends on the application of residual
insecticides and/or repellents. Although biological control agents have been developed against
aquatic mosquito stages, none are available for adults. Following successful use of an
entomopathogenic fungus against tsetse flies (Diptera: Glossinidae) we investigated the potency of
this fungus as a biological control agent for adult malaria and filariasis vector mosquitoes.
Methods: In the laboratory, both sexes of Anopheles gambiae sensu stricto and Culex quinquefasciatus
were passively contaminated with dry conidia of Metarhizium anisopliae. Pathogenicity of this fungus
for An. gambiae was further tested for varying exposure times and different doses of oil-formulated
conidia.
Results: Comparison of Gompertz survival curves and LT50 values for treated and untreated
specimens showed that, for both species, infected mosquitoes died significantly earlier (p < 0.0001)
than uninfected control groups. No differences in LT50 values were found for different exposure
times (24, 48 hrs or continuous exposure) of An. gambiae to dry conidia. Exposure to oil-
formulated conidia (doses ranging from 1.6 × 107 to 1.6 × 1010 conidia/m2) gave LT50 values of 9.69
± 1.24 (lowest dose) to 5.89 ± 0.35 days (highest dose), with infection percentages ranging from
4.4–83.7%.
Conclusion: Our study marks the first to use an entomopathogenic fungus against adult
Afrotropical disease vectors. Given its high pathogenicity for both adult Anopheles and Culex
mosquitoes we recommend development of novel targeted indoor application methods for the
control of endophagic host-seeking females.
Introduction
Malaria and bancroftian filariasis rank amongst the
world's most prevalent tropical infectious diseases. An
estimated 300–500 million people are infected with
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Lymphatic filariasis is probably the fastest spreading
insect-borne disease of man in the tropics, affecting about
146 million people [2]. The use of residual insecticides for
anopheline vector control, either through indoor house
spraying [3] or for bednet impregnation [4], has proven
highly effective in various parts of Africa, but is not with-
out obstacles. Emergence and spread of insecticide resist-
ance in anophelines [1,5–7], environmental pollution
[8], and unresolved issues pertaining to their toxicity to
humans and non-target organisms [3,9,10] hamper pro-
gressive use and broad acceptance of these tools. Limited
susceptibility and rapid build-up of resistance to synthetic
pyrethroids by culicine filariasis vectors [11], combined
with the availability of effective anti-filarial drugs [12], is
causing a gradual shift from vector control to mass-chem-
otherapy, though resurgence of transmission in the
absence of vector control remains problematic [13,14]. A
continued search for appropriate vector control strategies
to augment this limited arsenal of tools is called for [15],
and includes biological control methods [16,17].
Many biological control agents have been evaluated
against larval stages of mosquitoes, of which the most suc-
cessful ones comprise bacteria such as Bacillus thuringiensis
israelensis and B. sphaericus [18,19], mermithid nematodes
such as Romanomermis culicivorax [20], microsporidia such
as Nosema algerae [21], and several entomopathogenic
fungi [17]. Among these fungi, the oomycete Lagenidium
giganteum has proven successful for vector control in rice
fields [22] and is currently produced commercially [23].
Other mosquito-pathogenic fungi that target larval instars
include the chytidriomycetes Coelomomyces [24,61], and
the deuteromycetes Culicinomyces [25,62], Beauveria [26]
and Metarhizium [27]. Of the few fungi known to infect
adult Diptera, the majority belong to the group of Zygo-
mycetes (Entomophthoraleans) [28–30,63]. Unfortu-
nately, problems associated with growing
Entomophthoraleans in vitro have proven a major obsta-
cle for these fungi to be used for biological control [30].
Only a handful of studies have evaluated biological con-
trol agents/methodologies to control adult stages of trop-
ical disease vectors. Soarés [31] infected adult Ochlerotatus
sierrensis with the deuteromycete Tolypocladium cylin-
drosporum, resulting in 100% mortality after 10 days,
whereas Clark et al. [26] showed in a laboratory study that
adult mosquitoes of Culex tarsalis, Cx. pipiens, Aedes
aegypti, Ochlerotatus sierrensis, Ochlerotatus nigromaculis,
and Anopheles albimanus were susceptible to Beauveria bas-
siana. Recently, Scholte et al. [32] reported that adult An.
gambiae is susceptible to B. bassiana, a Fusarium spp., and
Metarhizium anisopliae.
M. anisopliae is a soil-borne metropolitan fungus and
infects predominantly soil-dwelling insects [33,34]. It has
a large host-range, including arachnids and five orders of
insects [35], comprising over 200 species. Although mos-
quitoes are not listed as natural hosts for M. anisopliae
[27,33] some strains have shown to be virulent against
mosquito larvae [27,36–40].
Spores (conidia) of M. anisopliae have been known for
some time to be infectious to adults and emerging pupae
of tsetse flies (Diptera: Glossinidae) [41,42] and novel
devices for exposing wild-caught specimens have been
developed [43]. Following our initial observation that the
same fungus is pathogenic to An. gambiae [32], we report
here on the effects of different exposure times to conidia-
treated substrates (24, 48 hrs or continuous exposure),
and dose-response experiments using oil-formulations of
conidia. In addition, we report the effects of continuous
exposure to conidia of adult Cx. quinquefasciatus.
Materials and Methods
Bioassays
Three different bioassays were conducted to study the
effect of:
1) dry conidia of M. anisopliae on infection and survival of
adult male and female An. gambiae s.s. and Cx. quinquefas-
ciatus. In this bioassay exposure of mosquitoes to conidia
was continuous throughout the experimental period;
2) limited exposure (24 or 48 hrs only) to dry conidia on
infection and survival of male and female An. gambiae s.s..
Following these periods the source of conidia was
removed to avoid further exposure;
3) different doses of conidia, formulated in sunflower oil
on infection and survival of female An. gambiae s.s..
Mosquitoes
Anopheles gambiae s.s. mosquitoes for bioassays 1 and 2
were obtained from a colony that originates from speci-
mens collected in Njage village in 1996, 70 km from
Ifakara town, in south-east Tanzania. All maintenance and
rearing procedures have been described in detail else-
where [44,45]. An. gambiae s.s. mosquitoes for bioassay 3
originated from Suakoko, Liberia (courtesy Prof. M.
Coluzzi). Rearing procedures for this strain were recently
described by Mukabana et al. [46]. Climatic conditions
were 18–30°C and 40–90% RH (bioassay 1), 28 ± 2° C
and 70 ± 5% RH (bioassay 2) and 27 ± 1°C and 80 ± 5%
RH (bioassay 3).
Bloodfed Cx. quinquefasciatus were collected daily from
local houses in Mbita Point, western Kenya. For bioassays,
only the F1 offspring from these wild mosquitoes wasPage 2 of 8
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lar conditions as the An. gambiae s.s. used in bioassay 1.
Fungus
Metarhizium anisopliae var. anisopliae (Metsch.) Sorokin,
isolate ICIPE-30 (courtesy Dr. N. Maniania) was used for
all three bioassays. The fungus was originally isolated in
1989 from a stemborer, Busseola fusca Fuller, near Kendu
Bay, western Kenya. Prior to use, fresh conidia were stored
in the dark at 4°C.
Experimental procedures
Bioassay 1
For each of three replicates, 30–50 male and female An.
gambiae s.s. or Cx. quinquefasciatus mosquitoes, aged 1–2
days at the start of the experiment, were placed in a 30 cm
cubic iron-framed cage covered with white mosquito net-
ting. These mosquitoes were offered a 6% glucose solu-
tion absorbed onto white laboratory filter-paper placed in
a glass vial (Figure 1). The paper was enveloped by a
locally available hair-roller ('suspensor'), basically a poly-
ethylene perforated tube (height 6.2 cm, diameter 2.5 cm)
with protruding, short plastic hairs that enlarged its sur-
face area. This suspensor was dusted with 100 mg of dry
conidia using a small paintbrush and carefully placed over
the filter-paper. Mosquitoes landing on the suspensor to
consume glucose would thus be exposed to conidia
through tarsal contact or on the head and thorax region
when feeding through the holes in the suspensor. The sus-
pensor remained in the cage until the end of the bioassay
(a minimum of 8 days), resulting in continuous exposure
of mosquitoes to the conidia whenever they consumed
glucose. The control group was exposed to a similar sus-
pensor, but without conidia. An estimation of conidia
density was made using a haemocyte counter (Fuch-
srosenthal®, 0.2 mm depth), showing that 100 mg of
conidia equalled approximately 6 × 108 conidia. Dead
mosquitoes were removed from the cage daily, placed on
moist filter-paper (distilled water) in a parafilm-sealed
petri dish, and examined for fungal growth after a few
days.
Bioassay 2
Experimental procedures were identical to those described
above, except that the source of conidia was removed
from the cages after either 24 or 48 hrs and replaced with
a non-contaminated source of glucose.
Bioassay 3
Conidia were inoculated on oatmeal agar and placed in an
incubator to grow for 2 weeks, after which fresh conidia
were harvested using a 0.05% Triton-x solution and a glass
rod. The solvent containing conidia was concentrated by
removing the supernatant after centrifuging for 3 min at
5000 rpm. Dilutions were made using 0.05% Tween 20 to
obtain conidia concentrations of 105, 106, 107, and 108
conidia/ml. Sunflower oil was added to these solvents to
obtain 10% oil-formulations for all solvents. For the bio-
assay, 1 ml of the various oil-formulations was pipetted
evenly over a 8 × 6 cm piece of filter-paper and left to dry
at 70% RH for 48 hrs, resulting in spore densities of 1.6 ×
107-1.6 × 1010 conidia/m2. These papers were gently
placed in cylindrical glass vials so that the paper coated
the inside of the vial. Mosquitoes were tested individually
by placing a 1 to 3 day-old female An. gambiae s.s. in a
vial, which was then sealed with cotton netting material.
For each dose, 10–15 mosquitoes were tested each time,
and all of the above procedures replicated thrice. Mosqui-
toes had access to a 6% glucose solution by placing freshly
soaked cotton wool pads on the netting daily. The filter-
paper was removed from the vial after three days, essen-
tially delivering tarsal exposure of mosquitoes to conidia
for 72 hrs. Dead mosquitoes were removed from the vials
The set-up used to contaminate mosquitoes with dry conidia of Metarhizi m anisopliaeFigure 1
The set-up used to contaminate mosquitoes with dry conidia 
of Metarhizium anisopliae. Dimensions are in cm.
6.2 
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paper. These were then sealed off and placed in an incuba-
tor at 27°C for three days, after which the cadavers were
checked for sporulating M. anisopliae using a dissection
microscope.
Data analysis
Survival curves were analysed by Kaplan-Meier pair-wise
comparison [47] and Cox regression analysis (using SPSS
11.0 and Genstat 5 software). For each trial, mosquito sur-
vival data were fitted to the Gompertz distribution model
[48] (using Genstat 5) as described by Clements and
Paterson [49], from which LT50 values were calculated.
LT50 values of treated versus control groups were com-
pared using paired sample t-tests.
Results
M. anisopliae showed to be pathogenic to adult male and
female An. gambiae s.s., both when mosquitoes were
exposed to oil-formulated or dry conidia. Cox regression
analysis showed that this pathogenicity was not depend-
ant on exposure time. Mosquitoes exposed to conidia for
24 or 48 hrs or continuously, died significantly faster (p <
0.001) than the untreated groups (Table 1). No significant
differences in survival were found between groups
exposed for either 24 or 48 hrs (p = 0.861), but there
appeared to be a trend that survival was lower under con-
tinuous exposure, compared to 24 or 48 hrs, although this
difference was also not significant (p = 0.092). Overall,
males died faster than females (p = 0.020). Following con-
tinuous exposure, 100% mortality of both male and
female An. gambiae was observed by day 7, at which time
an average of 41.7 and 82.3% of the respective sexes in the
control treatment were still alive.
In all bioassays where mosquitoes were exposed to dry
conidia, fungal sporulation was observed in > 95% of the
cadavers. For conidia in oil-formulations, percentage
sporulation was positively correlated with conidial dose.
Percentages ranged from 4.43 ± 4.4 % for mosquitoes that
had been exposed to the lowest, to 83.70 ± 8.3 % for those
that had been exposed to the highest dose (Table 2).
Mosquito survival data from all three bioassays closely fit-
ted the Gompertz distribution model (variance accounted
for ranged from 96.2–99.6%; Figure 2 and 3). Estimates of
Table 1: LT50 ± SE values for adult An. gambiae s.s. and Cx. quinquefasciatus exposed to dry conidia of the entomopathogenic fungus 
Metarhizium anisopliae for variable periods of time.
Species Exposure time Sex LT50 ± SE1 p-value2
Control Treated
An. gambiae s.s. continuous female 11.00 ± 0.58 5.08 ± 1.61 0.030
continuous male 7.65 ± 1.60 3.75 ± 0.29 0.042
48 hrs female 10.31 ± 1.30 3.80 ± 0.25 0.076
48 hrs male 11.66 ± 4.28 3.15 ± 0.37 0.125
24 hrs female 8.87 ± 1.32 3.39 ± 0.28 0.010
24 hrs male 11.68 ± 1.16 3.29 ± 0.59 0.048
Cx. quinquefasciatus continuous female 13.33 ± 2.91 3.88 ± 0.19 0.010
continuous male 18.00 ± 1.00 3.24 ± 0.23 0.010
1 standard error; 2 paired t-test
Table 2: Pair-wise Kaplan-Meier survival curve and LT50 comparison for adult Anopheles gambiae s.s. exposed to four different doses of 
sunflower oil-formulated Metarhizium anisopliae.
Dose1 Survival curves2 LT50 ± SE3 LT50-grouping2 % Infected
Control a 9.86 ± 1.16 a N/a
105 ab 9.37 ± 1.26 a 4.43 ± 4.4
106 bc 6.85 ± 0.44 b 32.63 ± 5.4
107 c 6.65 ± 0.43 b 59.74 ± 5.6
108 d 5.85 ± 0.26 b 83.70 ± 8.3
1 conidia per ml of 10% oil-formulation ; 2 treatments without letters in common are significantly different at P < 0.05; 3 standard error. N/a: not 
applicable.Page 4 of 8
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showed a dramatic reduction following exposure to
conidia. In the dose-response experiment, daily survival
rates were inversely related to the exposure dose. Table 3
shows estimated daily survival rates for An. gambiae at dif-
ferent ages for the doses tested.
Pair-wise comparisons of Kaplan-Meier data and survival-
curves for the different doses of exposure (Table 2, Figure
3) showed that mosquito survival in the untreated group
was not significantly different from that observed for mos-
quitoes exposed to the lowest dose (1.6 × 107 conidia/m2)
(p= 0.448). Survival of mosquitoes exposed to the two
intermediate doses (1.6 × 108 and 1.6 × 109 conidia/m2)
was significantly different from the lowest (1.6 ×
107conidia/m2) (p = 0.014 and p < 0.001), as well as the
highest (1.6 × 1010 conidia/m2) dose, (p = 0.001 and p =
0.014). LSD multiple comparison analysis of the LT50 val-
ues showed similar, but not equal cluster formation: the
five groups appeared to be divided into two clusters
(Table 2). One cluster contained the untreated group and
the dose 1.6 × 107 conidia/m2. Within this cluster the LT50
values were not significantly different from each other (p
= 0.668), but they were both significantly different from
the three other doses (p-values ranging between 0.003
and 0.040). Within this other cluster the LT50's did not
differ significantly from each other (p-values ranging
between 0.261 and 0.880).
As for An. gambiae, male Cx. quinquefasciatus died faster
than females (p < 0.001). Under continuous exposure,
100% mortality was reached at day 6 for males and at day
7 for females, at which time 85.3% and 90.0% of the
respective sexes in the control treatments were still alive.
Highly significant reductions in both male and female
survival were observed (Table 1).
Table 3: Estimated daily survival rates (± standard error), derived from the Gompertz model [see [49]], for female Anopheles gambiae 
s.s., following exposure to varying doses of oil-formulated conidia of Metarhizium anisopliae.
Days after exposure1 Dose (conidia/ml)
105 106 107 108 Control
3 0.98 (0.012) 0.93 (0.021) 0.92 (0.028) 0.93 (0.046) 0.97 (0.017)
7 0.83 (0.076) 0.73 (0.069) 0.69 (0.030) 0.51 (0.026) 0.87 (0.052)
10 0.80 (0.024) 0.77 (0.024) 0.37 (0.239) 0.22 (0.208) 0.81 (0.047)
1 Mosquitoes were 1–2 days old at the start of the experiment (day 0).
Gompertz survival curves for adult male and female Anophe-les gambiae s.s. infected with dry conidia of the entomopatho-genic fungu  Metarhizium anisopliae (pooled ata for 24/48 rs or continuo  xposure)Figur  2
Gompertz survival curves for adult male and female Anophe-
les gambiae s.s. infected with dry conidia of the entomopatho-
genic fungus Metarhizium anisopliae (pooled data for 24/48 hrs 
or continuous exposure).
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Epidemiological models on malaria and filariasis show
that adult mosquito survival is the most sensitive compo-
nent of vectorial capacity [50–52]. Notable reductions in
the life-span of female An. gambiae and Cx. quinquefascia-
tus will therefore have a considerable impact on reducing
the transmission risk of malaria and lymphatic filariasis.
For An. gambiae, daily survival rates (p) have been calcu-
lated for field populations, either from mark-release-
recapture studies or physiological state ratios of wild-
caught females. Takken et al. [53], using mark-release-
recapture methodology near Ifakara, southeast Tanzania,
estimated p to be 0.78. Gillies [54], using physiological
state methodology in the coastal lowlands of Tanzania,
found that female mortality rate was almost constant dur-
ing the 1-parous to 6-parous age period, with p being
0.85, but that it increased sharply thereafter. Killeen et al.
[55] arrived at a mean p value of 0.90, reflecting an
approximate median of estimates for four holoendemic
sites in Africa, which equals our estimates from the Gom-
pertz model.
The results from the current study show that the daily sur-
vival rates of M. anisopliae-infected adult mosquitoes at
any given moment in the mosquito's life span, is lower
than non-infected mosquitoes, and that their life span is
reduced, provided that the conidial dose is high enough.
If this is translated from a laboratory situation to the field
it could result (under favourable circumstances) in
reduced vectorial capacities of these mosquitoes. For Cx.
quinquefasciatus, life-expectancies of 30.82 ± 3.41 and
44.12 ± 4.19 days were found for caged male and females
in Tanzania [56]. Oda et al. [57] found mean longevities
of 39.8 (males) and 64.4 days (females), when kept in the
laboratory at 25°C. In our study we recorded lower
survival of uninfected specimens, but when 100% of the
treated female Cx. quinquefasciatus had died, 90 ± 6 % of
the untreated specimens were still alive, demonstrating
that this species is highly susceptible to infection with M.
anisopliae.
The correlation of increasing proportion of sporulation
with exposure of An. gambiae to increasing conidial doses
suggests that the mosquitoes' immune system is only able
to defend against the fungal infection at low doses, dimin-
ishing effectiveness when exposed to increasing conidial
doses. Mosquitoes may overcome a low infection level by
melanization and/or encapsulation of blastospores [58].
These defences would however have a cost to the mos-
quito's fitness [59,60], which is a possible explanation for
the positive correlation between conidial dose, mortality
rate and proportion of sporulation found in bioassay 3.
Unfortunately, in the present study we did not examine
mosquitoes for melanization.
For successful conidial attachment, fungal penetration
and, in the end, killing of a mosquito, a threshold number
of condia per unit surface area is required. In our dose-
response experiments the lowest dose resulting in a signif-
icant effect on mosquito survival was 1.6 × 108 conidia/
m2, equaling 160 conidia/mm2. Apart from the two claws
at the end of the last tarsus, the legs/tarsae of mosquitoes
are densely covered with hair-like structures ('feathers'),
which make it difficult for conidia to attach to the cuticula
of the tarsus. This was confirmed by observations under a
light microscope at magnification 40×. Several mosqui-
toes were gently removed from the contamination cage,
placed into a glass vial (they had been exposed for 24 hrs
to 1 × 106 conidia/ml of oil-formulated conidia on
impregnated filter-paper) and killed by adding a small
droplet of chloroform in the vial. Many conidia were
found attached to the 'feathers' of the last few tarsae, and
several at the 'feathers'of the tibia, but only few were actu-
ally attached to the cuticle. The ones that appeared to be
attached to the cuticle, were located near the end of the
last tarsus, around the claws, and in the intersegmental
areas of the tarsae, where very few 'feathers' are present.
Apparently the effective conidial dose (i.e. conidia that
actually attach to the mosquito's cuticle and subsequently
invade the integument and haemocoel) is an unknown,
but presumably it is a rather low fraction of the conidial
dosage that attaches to the mosquito. There appeared to
be considerable differences in LT50 values between An.
gambiae exposed to dry or to oil-formulated conidia. The
dose of dry conidia that was used was estimated to be 6 ×
108 conidia per suspensor. The suspensor has a surface
area 48.7 cm2, but has a 'hairy' surface area, containing
approximately 40 plastic 'hairs' (height 3.5 mm, diameter
0.5 mm) per cm2 suspensor surface, which increases its
surface area with an estimated 107 cm2 to 155.7 cm2,
resulting in a conidial dose per surface area of
approximately 5.6 × 1010 conidia/m2. This is 3.5 times
higher than the highest oil-formulated dose used in bio-
assay 3 (1.6 × 1010 conidia/m2).
When comparing the effects of indoor application of
residual insecticides, or bednets treated with synthetic
pyrethroids, on mosquito mortality, M. anisopliae delivers
lower overall mortality rates and speed of killing target
insects. However, apart from its demonstrated patho-
genicity to An. gambiae and Cx. quinquefasciatus, M. anisop-
liae exhibits several characteristics that make it an
attractive agent for biocontrol of adult mosquitoes in sub-
Saharan Africa. It can be mass-produced easily and
cheaply [23] and has a considerable shelf-life if stored
under proper conditions. The fungus is not harmful to
either birds, fish, or mammals [34] and since the fungus is
one of the most common entomopathogenic fungi, with
a worldwide distribution, its use for biocontrol would notPage 6 of 8
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the African ecosystem.
Conclusions
The experiments clearly showed that the malaria vector
An. gambiae s.s., and the filariasis vector Cx quinquefascia-
tus are susceptible to M. anisopliae. Their lifespan is greatly
reduced if contaminated with an appropriate dose of
conidia. As mosquito longevity is the single-most impor-
tant parameter in the vectorial capacity equation, pros-
pects for developing this adult mosquito control strategy
are promising and may in due course be developed into
an adult mosquito control tool. Questions regarding
application methodology, with the aim to optimize expo-
sure of vector mosquitoes to sources of fungal spores/
conidia, are currently being addressed.
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